Washington (AP) US health regulators on Friday authorised a new antibody drug that targets the omicron variant, a key step in restocking the nation’s arsenal against the latest version of COVID-19. The Food and Drug Administration said it cleared the Eli Lilly drug for adults and adolescent patients with mild-to-moderate cases of COVID-19. Lilly announced work […]